NMNAT is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Identity and purity are usually assessed with complementary methods. Nuclear magnetic resonance spectroscopy can confirm the molecular structure and distinguish anomeric forms. High-performance liquid chromatography with ultraviolet detection or mass spectrometry is common for assay and related-substance testing. Mass spectrometry also supports trace quantification in biological samples, often with isotope-labeled internal standards. Because NMN lacks a strong chromophore, some ultraviolet methods require careful wavelength selection or derivatization, and laboratories may validate each approach for its intended matrix.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C11H15N2O8P | Canonical beta anomer; charge state depends on pH. |
| Molar mass | 334.22 g/mol | Calculated for the neutral formula. |
| CAS Registry Number | 1094-61-7 | Common identifier for beta-nicotinamide mononucleotide. |
| Appearance | White to off-white powder or crystals | Varies with purity, hydration, and polymorphism. |
| Solubility | Freely soluble in water; low solubility in nonpolar solvents | Reported values depend on salt form and temperature. |
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
Solid NMN is generally handled as a moisture-sensitive and light-sensitive material. Suppliers commonly recommend storage at minus 20 degrees Celsius in a sealed, desiccated container, protected from light. Aqueous solutions are less stable than the solid and may degrade faster at elevated temperatures or extreme pH values. Because NMN contains a phosphate ester and a glycosidic bond, hydrolysis and other degradation pathways are plausible under unfavorable conditions. Stability data from independent laboratories remain limited, so handling recommendations often reflect supplier practice rather than published consensus.
Analytical measurement of NMN typically uses high-performance liquid chromatography with ultraviolet detection, often at a wavelength near 260 nanometers. Liquid chromatography coupled with tandem mass spectrometry provides greater sensitivity and specificity, especially for biological samples. Nuclear magnetic resonance spectroscopy can confirm structure and detect certain impurities. Purity values reported by suppliers depend on the analytical method, calibration standards, and whether related compounds such as nicotinamide or NAD+ are included in the calculation. Independent verification is useful because supplement labels may not fully describe the tested material.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
==== Emerging foodborne pathogens ==== Aeromonas hydrophila, Aeromonas caviae, Aeromonas sobria Scandinavian outbreaks of Yersinia enterocolitica have recently increased to an annual basis, connected to the non-canonical contamination of pre-washed salad.
==== Egg tofu ==== Egg tofu (Japanese: 玉子豆腐, 卵豆腐, tamagodōfu) (Chinese: 蛋豆腐, dàndòufu; often called 日本豆腐, Rìbĕn dòufu, lit. "Japan bean curd") is the main type of savory flavored tofu. Whole beaten eggs are combined with dashi, poured into molds, and cooked in a steamer (cf. chawanmushi). This tofu has a pale golden color that can be attributed to the addition of eggs and, occasionally, food coloring. This tofu has a fuller texture and flavor than silken tofu, due to the presence of egg fat and proteins. Plain "dried tofu" can be flavored by stewing in soy sauce (滷) to make soy-sauce tofu. It is common to see tofu sold from hot food stalls in this soy-sauce stewed form. Today egg "Japanese" tofu is made of eggs, water, vegetable protein, and seasoning. Egg tofu was invented in Japan during the Edo period. The book 万宝料理秘密箱 written in 1785 recorded how to make Japanese tofu. Later the Japanese form of tofu entered Southeast Asia, being introduced to China in 1995 from Malaysia. 100 grams of egg tofu has 17 mg calcium, 24 mg magnesium, and 5 grams protein while 100 grams tofu has 138 mg calcium, 63 mg magnesium and 12.2 grams protein. Compared with tofu, Japanese tofu's nutritional value is lower.
He had to leave the game after the seventh with a pulled back muscle, but he was back in action four days later. He won just twice more all season, as he dealt with back problems. On August 1, he again struck out eight Phillies but received a no decision, as he was removed with one out in the ninth and the game tied 1–1. The Cardinals won on a Stan Musial home run in the bottom of the inning. In 31 games (30 starts), he had a 13–10 record, a 4.20 ERA, 108 strikeouts, and 89 walks in 201+1⁄3 innings pitched. By 1960, Mizell had recovered from his back issues. He began the season with the Cardinals but only won one of his first nine games, posting a 4.55 ERA. By this point, the Cardinals felt that he had never attained his full potential. On May 28, they traded him and Dick Gray to the Pirates for Ed Bauta and Julián Javier, the latter of whom would reach two All-Star Games and win two World Series with the Cardinals over the next decade.
A study was conducted by Siamak Khodarahimi to determine the roles of gender and age on positive psychology constructs – psychological hardiness, emotional intelligence, self-efficacy and happiness – among 200 Iranian adolescents and 200 young adults who were questioned through various tests. The study found that the males of the sample showed significantly higher rates in psychological hardiness, emotional intelligence, self-efficacy and happiness than females, regardless of age.
== Investigation == Cell-matrix adhesions have been more extensively investigated by proteomics compared with cell-cell adhesions because they are more readily isolated from cells attached to glass. The advent of proximity biotinylation by birA* has facilitated the first proteomics-based studies of the cadherin adhesome.
Sources: en.wikipedia.org
== Pathophysiology == The symptoms are caused by an allergic reaction of the host's body to mite proteins, though exactly which proteins remains a topic of study. The mite proteins are also present in the gut, and in mite feces, which are deposited under the skin. The allergic reaction is both of the delayed (cell-mediated) and immediate (antibody-mediated) type, and involves IgE (antibodies are presumed to mediate the very rapid symptoms on reinfection). The allergy-type symptoms (itching) continue for some days, and even several weeks, after all mites are killed. New lesions may appear for a few days after mites are eradicated. Nodular lesions from scabies may continue to be symptomatic for weeks after the mites have been killed. Rates of scabies are negatively related to temperature and positively related to humidity.
== Production and effects == Artificial production methods of radionuclides include neutron sources such as nuclear reactors, as well as particle accelerators such as cyclotrons. The radiation from radionuclides generally has a harmful effect on organisms including humans, although low levels of exposure occur naturally. The degree of harm depends on the nature and extent of the radiation (alpha, beta, gamma, or neutron), the amount and nature of exposure (close contact, inhalation or ingestion), and the element's biochemical properties (toxicity). Increased risk of cancer is unavoidable, and worse cases induce cancer, chronic radiation syndrome or acute radiation syndrome. Radionuclides can be used as weapons by the fallout effects of nuclear weapons and by radiological weapons. Radionuclides are used in nuclear medicine for both diagnosis and treatment. The term “theranostics” (or “theragnostics”) refers to the combination of diagnosis and therapy of a disease within a single medical procedure or technique. An imaging tracer made with radionuclides is a radioactive tracer. Radionuclide therapy is a form of radiotherapy. A pharmaceutical drug made with radionuclides is called a radiopharmaceutical.
== Research == His research proposed that peptide hormones are produced from large precursor proteins. In 1967, Chrétien first articulated the prohormone theory, proposing that peptide hormones are produced from larger precursors, a paradigm later widely confirmed and foundational for modern endocrinology. In 1976, his team discovered human β-endorphin, advancing understanding of endogenous opioid systems in pain and stress biology. In 1990, Chrétien and collaborators identified the family of proprotein convertases (PCs/PCSK1–9), endoproteases that activate many precursor proteins and hormones, helping to establish a field often termed “functional endoproteolysis.” A loss-of-function PCSK9 variant characterized in French-Canadian families by Chrétien’s group is associated with markedly low LDL cholesterol and cardioprotection, work that helped validate PCSK9 as a therapeutic target. Chrétien’s prohormone/convertase research has had broad clinical impact, informing therapies and biological understanding in diabetes, obesity, dyslipidemia, atherosclerosis, cancer, opiate use disorders, and Alzheimer’s disease. Between 1981 and 1990, he ranked among the world’s most-cited scientists (reported as seventh globally) reflecting the reach of his contributions.
== Bibliography == Antoni Czubiński, Powstanie Wielkopolskie 1918–1919. Geneza-charakter-znaczenie, Poznań 1978 Antoni Czubiński, Rola Powstania Wielkopolskiego w walce narodu polskiego o powstrzymanie niemieckiego >parcia na wschód<, Przegląd Zachodni 1968, nr 5–6 A. Czubiński, Z.Grot, B.Miśkiiewcz, Powstanie Wielkopolskie 1918–1919. Zarys dziejów, Warszawa 1978 K. Dembski, Wielkopolska w początkach II Rzeczypospolitej. Zagadnienia prawno-ustrojowe, Poznań 1972 Roman Dmowski, Polityka polska i odbudowanie państwa 1925 Z. Grot (ed.), Powstanie wielkopolskie 1918–1919, Poznań 1968 Z. Grot, I. Pawłowski, M. Pirko, Wielkopolska w walce o niepodległość 1918–1919. Wojskowe i polityczne aspekty Powstania Wielkopolskiego, Warszawa 1968 P. Hauser, Niemcy wobec sprawy polskiej X 1918–VI 1919, Poznań 1984 K. Kandziora, Działalność POW w Poznaniu. Przyczynek do historii Polskiej Organizacji Wojskowej zaboru pruskiego w latach 1918–1919, Warszawa 1939 S. Kubiak, Niemcy a Wielkopolska 1918–1919, Poznań 1969 Joseph Lamia: Der Aufstand in Posen (The Uprising in Poznan). Berlin 1919 (in German). Materiały Sesji Naukowej z okazji 50-lecia Powstania Wielkopolskiego 1918/1919, Zaszyty Naukowe UAM 1970, Historia t.10 Witold Mazurczak, Anglicy i wybuch powstania wielkopolskiego. Z dziejów genezy brytyjskiej misji płka H.H.Wade'a w Polsce, [in:] Antoni Czubiński (ed.), Polacy i Niemcy. Dziesięć wieków sąsiedztwa, PWN, Warszawa 1987 Janusz Pajewski, Rodział XXII.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ metabolism. It occurs naturally in cells and can also be produced synthetically for research or commercial use. Its name reflects its composition: nicotinamide, ribose, and a phosphate group.
NMN is a direct precursor in the NAD+ salvage pathway. NMNAT enzymes convert NMN and ATP into NAD+, a coenzyme used in many cellular reactions. This relationship makes NMN a focus of studies on NAD+ metabolism.
Small amounts of NMN have been reported in some plant foods, but measured levels vary and are not consistently quantified. Dietary contribution is generally considered minor compared with endogenous production. Food-matrix effects make accurate analysis difficult.
Purity is commonly measured by high-performance liquid chromatography with ultraviolet or mass spectrometric detection. Nuclear magnetic resonance can confirm identity and anomeric composition. Water content and residual solvents may be tested separately.